Pharmafile Logo

B2B sales

- PMLiVE

Paywatch and the market access waters

Understanding and responding to payers’ needs has become priority number one for pharma

Apple launches CareKit mHealth developer software

Makes its debut alongside apps for reproductive health, diabetes and depression

Understanding personas for healthcare

In this article, Head of Insight Martine Leroy tackles the persona. Here, she breaks down for us what a persona is in the context of customer-centric design, and addresses some...

Blue Latitude Health

Boehringer Ingelheim PM Society Digital Awards 2016 social media

Social media win for Boehringer at PM Society Digital Awards

Sees off competition from AbbVie, Bayer, Novartis and Pfizer

Bristol-Myers Squibb (BMS) building

BMS claims 80% market share for Opdivo in US

New indications and label updates boost the cancer immunotherapy’s market position

- PMLiVE

AbbVie adds to cancer portfolio with $9.8bn Stemcentrx deal

Continues to build its oncology business to lessen its reliance on Humira

Is it possible to change behaviour virtually?

Changing behaviour requires a combination of science and art. As technology evolves, so does the breadth of mechanisms (the ‘art’) through which we can deliver science-based, behaviour-change interventions. As the...

- PMLiVE

Quintiles promotes Robert Taylor

He becomes head of Europe, commercial solutions

- PMLiVE

Merck appoints ex-Pfizer exec as global head of oncology

Maya Martinez-Davis succeeds Andrew Schiermeier in the role

Incisive Health Bill Morgan Sarah Winstone Mike Birtwistle

Incisive Health goes international with Brussels office

Follows work for the likes of AbbVie, EFPIA and the Global Lung Cancer Coalition

Porterhouse Medical Brian Parsons Jon Hallows

Queen’s Awards for Enterprise for STEM and Porterhouse

International trade honours recognise the two firms' rapid overseas expansion

Sanofi reception

Sanofi makes $9.3bn unsolicited bid for Medivation

Hopes to boost oncology business with fast-growing prostate cancer drug Xtandi

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links